Repros Therapeutics (RPRX) Reports Q2 Loss of $0.18/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $59.45 +1.45%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q2 EPS of ($0.18), versus ($0.32) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- InspireMD (NSPR) Tops Q2 EPS by 1c
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
